An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control System

Abstract

The benefits of and indications for cyproheptadine are uncertain and questionable for the management of a serotonin syndrome. Future recommendations on its use should be based on diagnostic criteria, severity of symptoms and management in conjunction with other supportive measures.